MedPath

Cardiac Implants LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Early Feasibility Study of the Cardiac Implants Percutaneous Ring Annuloplasty System

Not Applicable
Recruiting
Conditions
Tricuspid Regurgitation Functional
First Posted Date
2021-05-18
Last Posted Date
2021-11-30
Lead Sponsor
Cardiac Implants LLC
Target Recruit Count
15
Registration Number
NCT04890821
Locations
🇺🇸

Hackensack University Medical Center, Hackensack, New Jersey, United States

🇺🇸

Weill Cornell Medicine-New York Presbyterian Hospital, New York, New York, United States

First in Human Study of the DaVingi™ TR System in the Treatment of Patients With Functional Tricuspid Regurgitation

Not Applicable
Conditions
Functional Tricuspid Regurgitation (TR)
First Posted Date
2018-10-09
Last Posted Date
2021-11-12
Lead Sponsor
Cardiac Implants LLC
Target Recruit Count
15
Registration Number
NCT03700918
Locations
🇨🇿

Na Homolce Hospital, Prague, Czechia

🇫🇷

Hopital Bichat, Paris, France

🇫🇷

Institut Mutualiste Montsouris, Paris, France

and more 2 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath